Summary
Simplify Propel Opportunities ETF is an ETF - a fund traded on an exchange like a stock - run by Simplify. Positions inside: 39. The ten largest make up 83% of the fund.
- Yearly costs
- 2.82%
- Fund size
- $74.0M
- Positions
- 39
- Dividend yield
- 16.82%
- Running since
- 2023
What speaks for it
Nothing stands out in its favour.
What to watch
- The ten largest positions make up 83% of the fund, so its result rests on a few names.
- 51% of the fund is in one sector (Healthcare).
- 93% of the fund is in one country (United States).
- Costs of 2.82% a year are above the middle of comparable funds (0.44%).
- In the last five years its price once dropped by 52% from its high.
- A small fund with $74.0M under management; small funds get closed more often.
- It trades little: only about $75.2K changes hands a day.
A fund has no Bulios Score and no Fair Price of its own - both are computed from the results of a single company. This page shows what is inside the fund and what it costs instead.
Price
Performance
- 1 month
- -3.0%
- 3 months
- -8.4%
- This year
- -0.8%
- 1 year
- +1.3%
- 3 years
- -14%
- Avg. market cap
- $3.58B
- P/E
- 11.3x
- Forward P/E
- 9.8x
- P/S
- 0.2x
- P/B
- 3.2x
- P/FCF
- 2.3x
- EV/EBITDA
- 5.2x
- Dividend yield
- 3.36%
- ROIC
- -2,108.2%
- ROE
- -100.0%
- Gross margin
- -705.1%
- Operating margin
- -10,170.9%
- Net margin
- -14,174.5%
- Payout ratio
- 38.0%
- Net debt/EBITDA
- 0.4x
- Beta
- 1.18
Weighted average of the 23 largest companies, which make up 88% of the fund. Banks and insurers are left out of the gross margin, the ROIC and the EBITDA figures.
What is inside?
Concentrated- 1 PAPlains GP Holdings, L.P. PAGP 49%
- 2 ACAchieve Life Sciences, Inc. ACHV 8.6%
- 3 ACHIEVE LIFE SCIENCES I WTS 30JUN30 5.0%
- 4 DCDelcath Systems, Inc. DCTH 4.3%
- 5 Cash 4.3%
- 6 MIMilestone Pharmaceuticals Inc. MIST 3.3%
- 7 COCollegium Pharmaceutical, Inc. COLL 3.0%
- 8 COCorcept Therapeutics CORT 2.3%
- 9 PHPhathom Pharmaceuticals, Inc. PHAT 1.9%
- 10 ABAbeona Therapeutics Inc. ABEO 1.6%
Positions in the fund: 39. The ten largest make up 83% of it.
Composition as of Oct 31, 2026.
Where is it spread?
One sector dominatesBy sector
- Healthcare 51%
- Energy 49%
By country
- United States 93%
- Canada 4.0%
- France 1.8%
- United Kingdom 1.7%
By company size
- Mid cap 59%
- Small cap 30%
- Micro cap 11%
By the company's market value: Mega cap from $200B, Large cap from $10B, Mid cap from $2B, Small cap from $300M, Micro cap below $300M. Counted from the companies that make up 88% of the fund.
Largest sector: Healthcare (51%). Largest country: United States (93%). Largest size group: Mid cap (59%).
What does it cost me?
Expensive- A year from $10,000
- $282
- Over 20 years
- $11,140
From every $10,000 invested the fund takes $282 a year. You do not pay it separately - it is taken out of the fund's value. Over 20 years at 5% yearly growth that adds up to about $11,140.
How has it done?
Losing value- A year on average, 3 years
- -5.0%
- Deepest drop
- -52%
- Yearly volatility
- 23%
Average yearly decline over the last three years: 5.0%. Deepest drop in these years: 52% below the earlier high.
Does it pay dividends?
Yes, it pays out- Yield
- 16.82%
- Payments a year
- 4
- Last payment
- $0.68
Over the last 12 months it paid $2.72 per share, which is 16.82% of today's price. The last payment was $0.68 on Sep 25, 2026.
Is it easy to buy and sell?
It trades little- Traded a day
- $75.2K
- Shares a day
- 4.7K
On an average day about $75.2K of the fund changes hands.
How expensive are the companies inside?
Rather cheap- P/E of the companies inside
- 11.3
- Average Bulios Score
- 48 out of 100
Weight by Bulios Fair Price
- Undervalued 70%
- Fairly valued 0.0%
- Overvalued 30%
On average the companies inside trade for 11.3 times their yearly profit. By Fair Price, 70% of the rated weight comes out as undervalued.
Counted from its largest companies (23), which make up 88% of the fund. Each company counts by its weight. We use the metrics, the Bulios Score and the Fair Price of the companies themselves.